Psychiatric assessment for patients who decline cancer treatment: perspectives from medical residents.
Anxiety disorders
Depression
Mental disorders
Neoplasms
Schizophrenia
Treatment refusal
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
27 Aug 2024
27 Aug 2024
Historique:
received:
27
03
2024
accepted:
13
08
2024
medline:
27
8
2024
pubmed:
27
8
2024
entrez:
27
8
2024
Statut:
epublish
Résumé
Among patients with cancer, a comorbid mental disorder is associated with higher mortality. This could be partially attributed to reduced access to oncological care, sometimes due to treatment refusal. Recommendations were issued in 2018 by the French and Francophone Society of Psycho-Oncology concerning the management of oncological treatment refusal. This study aimed to examine oncology residents' view on psychiatric assessment in this context. In February 2021, we conducted a descriptive, observational, cross-sectional pilot study among French residents involved in oncology regarding their management of cancer treatment refusal and the importance they assign to psychiatric assessment, using an online questionnaire with 12 multiple-choice questions. Among 87 respondents, only 35.6% systematically explore the history of mental disorders when facing cancer treatment refusal. Even in cases with a known history of mental disorders, only 42.5% systematically refer the patient to a psychiatrist. 96.5% of them were unaware of the 2018 recommendations. The importance given to psychiatric assessment in cases of oncological treatment refusal remains insufficient. Qualitative studies are needed to understand the underlying reasons for this refusal. The development of psychiatric consultation-liaison interventions in oncology centers is necessary to improve the management of these cases and provide appropriate training.
Identifiants
pubmed: 39190138
doi: 10.1007/s00520-024-08806-7
pii: 10.1007/s00520-024-08806-7
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
614Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M (2017) Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 4(4):295–301
doi: 10.1016/S2215-0366(17)30078-0
pubmed: 28237639
Coldefy M, Gandré C (2018) Personnes suivies pour des troubles psychiques sévères: une espérance de vie fortement réduite et une mortalité prématurée quadruplée. IRDES 237:1–8. Retrieved December, 2020, from https://www.irdes.fr/recherche/questions-d-economie-de-la-sante/237-personnes-suivies-pour-des-troubles-psychiques-severes-une-esperance-de-vie-fortement-reduite.pdf
Fond G, Baumstarck K, Auquier P, Fernandes S, Pauly V, Bernard C et al (2020) Recurrent major depressive disorder’s impact on end-of-life care of cancer: a nationwide study. J Affect Disord 263:326–335. https://doi.org/10.1016/j.jad.2019.12.003
doi: 10.1016/j.jad.2019.12.003
pubmed: 31969262
Fond G, Salas S, Pauly V, Baumstarck K, Bernard C, Orleans V et al (2019) End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database. Lancet Public Health 4:583–591. https://doi.org/10.1016/S2468-2667(19)30187-2
doi: 10.1016/S2468-2667(19)30187-2
Fond G, Baumstarck K, Auquier P, Pauly V, Bernard C, Orleans V et al (2020) End-of-life care among patients with bipolar disorder and cancer: a nationwide cohort study. Psychosom Med 8:722–732. https://doi.org/10.1097/PSY.0000000000000839
doi: 10.1097/PSY.0000000000000839
Lemogne C (2010) Dépression et cancers: facteur de risque ou perte de chance ? Psycho Oncologie 4:281–282. https://doi.org/10.1007/s11839-010-0292-4
doi: 10.1007/s11839-010-0292-4
Ishikawa H, Yasunaga H, Matsui H, Fushimi K, Kawakami N (2016) Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study. Br J Psychiatry 208:239–244. https://doi.org/10.1192/bjp.bp.114.156265
doi: 10.1192/bjp.bp.114.156265
pubmed: 26585096
Kisely S, Crowe E, Lawrence D (2013) Cancer-related mortality in people with mental illness. JAMA Psychiatry 70(2):209. https://doi.org/10.1001/jamapsychiatry.2013.278
Dauchy S (2013) Troubles psychiatriques en oncologie: éviter la perte de chance. 11ème congrès de l’Association Nationale pour la Promotion des Soins Somatiques en Santé Mentale, Marseille. Retrieved January, 2021, from https://www.anp3sm.com/wp-content/uploads/2014/06/Sarah_DAUCHY.pdf
Humphreys K, Blodgett JC, Roberts LW (2015) The exclusion of people with psychiatric disorders from medical research. J Psychiatr Res 70:28–32
doi: 10.1016/j.jpsychires.2015.08.005
pubmed: 26424420
DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107. https://doi.org/10.1001/archinte.160.14.2101
doi: 10.1001/archinte.160.14.2101
pubmed: 10904452
Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA et al (2011) Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 26:1175–1182. https://doi.org/10.1007/s11606-011-1704-y
doi: 10.1007/s11606-011-1704-y
pubmed: 21533823
pmcid: 3181287
Levin JB, Aebi ME, Tatsuoka C, Cassidy KA, Sajatovic M (2016) Adherence to psychotropic and nonpsychotropic medication among patients with bipolar disorder and general medical conditions. Psychiatr Serv 67(3):342–345
doi: 10.1176/appi.ps.201500010
pubmed: 26695494
Gorczynski P, Firth J, Stubbs B, Rosenbaum S, Vancampfort D (2017) Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis. Psychiatry Res 250:17–24
doi: 10.1016/j.psychres.2017.01.049
pubmed: 28135643
Hwang M, Farasatpour M, Williams CD, Margenthaler JA, Virgo KS, Johnson FE (2012) Adjuvant chemotherapy for breast cancer in patients with schizophrenia. Oncol Lett 3:245–850. https://doi.org/10.3892/ol.2012.560
doi: 10.3892/ol.2012.560
Dauchy S, Faivre JC, Block V, Metzger M, Salleron J, Charles C et al (2018) Le refus de soins chez un patient adulte atteint de cancer : recommandations de prise en charge de l’AFSOS et de la SFPO. Bull Cancer 105:234–244. https://doi.org/10.1016/j.bulcan.2017.11.016
doi: 10.1016/j.bulcan.2017.11.016
pubmed: 29478572
Faivre JC, Adam V, Block V, Metzger M, Salleron J, Dauchy S et al (2017) Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer. Support Care Cancer 25:3425–3435. https://doi.org/10.1007/s00520-017-3762-0
doi: 10.1007/s00520-017-3762-0
pubmed: 28597252
Konstantakopoulos G, Ploumpidis D, Oulis P, Patrikelis P, Soumani A, Papadimitriou GN et al (2011) Apathy, cognitive deficits and functional impairment in schizophrenia. Schizophr Res 133:193–198. https://doi.org/10.1016/j.schres.2011.07.003
doi: 10.1016/j.schres.2011.07.003
pubmed: 21788116
D’Argembeau A, Raffard S, Van der Linden M (2008) Remembering the past and imagining the future in schizophrenia. J Abnorm Psychol 117:247–251. https://doi.org/10.1037/0021-843X.117.1.247
doi: 10.1037/0021-843X.117.1.247
pubmed: 18266503
Reich M, Gaudron C (2009) Caractéristiques et prise en charge du patient psychotique en cancérologie. Bull Cancer 96:227–237. https://doi.org/10.1684/bdc.2008.0817
doi: 10.1684/bdc.2008.0817
pubmed: 19258229
Granek L, Nakash O, Ariad S, Shapira S, Ben-David M (2018) Oncologists’ identification of mental health distress in cancer patients: strategies and barriers. Eur J Cancer Care 27:12835. https://doi.org/10.1111/ecc.12835
doi: 10.1111/ecc.12835
Khankeh HR, Vodjani R, Saber M, Imanieh M (2023) How do cancer patients refuse treatment? A grounded theory study. BMC Palliat Care 22:1–10. https://doi.org/10.1186/s12904-023-01132-5
doi: 10.1186/s12904-023-01132-5
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174. https://doi.org/10.1016/S1470-2045(11)70002-X
doi: 10.1016/S1470-2045(11)70002-X
pubmed: 21251875
Grassi L, Nanni MG, Caruso R (2010) Emotional distress in cancer: screening policy, clinical limitations, and educational needs. J Med Person 8:51–59. https://doi.org/10.1007/s12682-010-0047-5
doi: 10.1007/s12682-010-0047-5
Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C et al (2014) Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet 384(9948):1099–1108. https://doi.org/10.1016/S0140-6736(14)61231-9
doi: 10.1016/S0140-6736(14)61231-9
pubmed: 25175478
Irwin K, Park E, Fields L, Corveleyn A, Greer J, Perez G et al (2019) Bridge: person-centered collaborative care for patients with serious mental illness and cancer. Oncologist 24(7):901–910. https://doi.org/10.1634/theoncologist.2018-0488
doi: 10.1634/theoncologist.2018-0488
pubmed: 30696722
pmcid: 6656464
Stiefel F, Bourquin C, Salmon P, Achtari Jeanneret L, Dauchy S, Ernstmann N et al (2024) Communication and support of patients and caregivers in chronic cancer care: ESMO clinical practice guideline. ESMO Open. https://doi.org/10.1016/j.esmoop.2024.103496
doi: 10.1016/j.esmoop.2024.103496
pubmed: 39089769